• Consensus Rating: Moderate Buy
  • Consensus Price Target: $83.57
  • Forecasted Upside: 4.18%
  • Number of Analysts: 12
  • Breakdown:
  • 0 Sell Ratings
  • 6 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$80.22
▲ +0.15 (0.19%)

This chart shows the closing price for CNC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Centene Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CNC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CNC

Analyst Price Target is $83.57
▲ +4.18% Upside Potential
This price target is based on 12 analysts offering 12 month price targets for Centene in the last 3 months. The average price target is $83.57, with a high forecast of $110.00 and a low forecast of $72.00. The average price target represents a 4.18% upside from the last price of $80.22.

This chart shows the closing price for CNC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 12 investment analysts is to moderate buy stock in Centene. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 0 sell ratings
9/2/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 0 sell ratings
12/1/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 0 sell ratings
3/1/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 0 sell ratings
5/30/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 0 sell ratings
8/28/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 0 sell ratings
11/26/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 0 sell ratings
1/25/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 0 sell ratings
2/24/2024

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/2/2024Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$82.00 ➝ $90.00Low
12/21/2023Truist FinancialBoost TargetBuy ➝ Buy$83.00 ➝ $86.00Low
12/21/2023UBS GroupBoost TargetNeutral ➝ Neutral$72.00 ➝ $79.00Low
12/15/2023Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$82.00 ➝ $90.00Low
12/13/2023Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$74.00 ➝ $82.00Low
11/21/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$82.00Low
10/26/2023Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$71.00 ➝ $74.00Low
10/9/2023Jefferies Financial GroupLower TargetBuy ➝ Buy$82.00 ➝ $81.00Low
9/14/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$82.00Low
9/5/2023Bank of AmericaUpgradeUnderperform ➝ Neutral$79.00 ➝ $72.00Low
8/30/2023Morgan StanleyDowngradeOverweight ➝ Equal Weight$94.00 ➝ $73.00Low
7/31/2023OppenheimerReiterated RatingOutperform ➝ Outperform$110.00Low
7/31/2023StephensLower Target$87.00 ➝ $85.00Low
7/31/2023BarclaysLower TargetOverweight$86.00 ➝ $85.00Low
7/14/2023Morgan StanleyReiterated RatingOverweight ➝ Overweight$94.00Low
7/12/2023Wolfe ResearchDowngradeOutperform ➝ Peer PerformLow
7/11/2023MizuhoLower Target$80.00 ➝ $76.00Low
7/7/2023JPMorgan Chase & Co.Lower Target$81.00 ➝ $77.00Low
6/20/2023Truist FinancialLower Target$88.00 ➝ $83.00Low
6/20/2023UBS GroupInitiated CoverageNeutral$72.00Low
4/26/2023StephensLower Target$95.00 ➝ $87.00Low
4/26/2023Credit Suisse GroupLower Target$94.00 ➝ $87.00Low
4/26/2023BarclaysLower Target$90.00 ➝ $86.00Low
4/20/2023Cantor FitzgeraldInitiated CoverageOverweight$80.00Low
4/11/2023BarclaysLower TargetOverweight$93.00 ➝ $90.00Low
3/21/2023Wells Fargo & CompanyLower TargetEqual Weight$79.00 ➝ $71.00Low
3/9/2023Morgan StanleyLower TargetOverweight$103.00 ➝ $94.00Low
3/8/2023Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$94.00 ➝ $79.00Low
2/28/2023MizuhoLower TargetNeutral$92.00 ➝ $80.00Low
2/23/2023JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$94.00 ➝ $90.00Low
2/14/2023CowenLower TargetOutperform$101.00 ➝ $97.00Low
2/8/2023The Goldman Sachs GroupLower TargetNeutral$97.00 ➝ $74.00Low
2/8/2023MizuhoReiterated RatingNeutral$92.00Low
2/8/2023JPMorgan Chase & Co.Lower TargetOverweight$98.00 ➝ $94.00Low
2/8/2023Loop CapitalLower Target$110.00 ➝ $95.00Low
2/8/2023BarclaysLower TargetOverweight$100.00 ➝ $93.00Low
1/6/2023JPMorgan Chase & Co.Lower TargetOverweight$103.00 ➝ $98.00Low
12/19/2022Credit Suisse GroupBoost TargetOutperform$104.00 ➝ $106.00Low
12/14/2022ArgusBoost Target$95.00 ➝ $99.00Low
12/13/2022Bank of AmericaDowngradeNeutral ➝ Underperform$100.00 ➝ $85.00Low
10/26/2022Deutsche Bank AktiengesellschaftLower Target$99.00 ➝ $94.00Low
10/3/2022BarclaysLower TargetOverweight$107.00 ➝ $100.00Low
9/30/2022ArgusInitiated CoverageBuy$90.00Low
9/22/2022CowenLower Target$108.00 ➝ $101.00Low
9/22/2022CowenLower Target$108.00 ➝ $101.00Low
8/26/2022Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$103.00 ➝ $99.00Low
8/9/2022CowenBoost Target$108.00N/A
7/28/2022BarclaysInitiated CoverageOverweight ➝ Overweight$107.00Low
7/27/2022StephensBoost TargetOutperform$110.00Low
7/27/2022OppenheimerBoost TargetOutperform$110.00Low
7/27/2022Truist FinancialBoost TargetOutperform$102.00 ➝ $110.00Low
7/27/2022Deutsche Bank AktiengesellschaftBoost Target$91.00 ➝ $99.00Low
7/19/2022Credit Suisse GroupSet Target$97.00Low
7/14/2022Jefferies Financial GroupUpgradeHold ➝ Buy$82.00 ➝ $115.00Low
7/14/2022Truist FinancialBoost TargetBuy$100.00 ➝ $102.00Low
6/23/2022Morgan StanleyLower TargetOverweight$112.00 ➝ $103.00Low
6/22/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$88.00 ➝ $91.00Low
6/21/2022Credit Suisse GroupUpgradeNeutral ➝ Outperform$86.00 ➝ $88.00Low
6/16/2022Loop CapitalInitiated CoverageBuy$100.00Low
5/26/2022Sanford C. BernsteinInitiated CoverageOutperform$111.00 ➝ $108.00High
5/26/2022Bank of AmericaDowngradeBuy ➝ Neutral$95.00 ➝ $90.00Medium
5/25/2022Wells Fargo & CompanyLower TargetOverweight$96.00 ➝ $95.00Low
2/9/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$84.00 ➝ $88.00Low
2/9/2022MizuhoBoost TargetNeutral$78.00 ➝ $84.00Medium
1/11/2022Sanford C. BernsteinBoost Target$94.00 ➝ $108.00High
1/7/2022BarclaysInitiated CoverageOverweight ➝ Overweight$95.00Medium
1/5/2022Truist FinancialBoost TargetBuy ➝ Buy$94.00 ➝ $96.00High
12/17/2021Morgan StanleyBoost TargetOverweight$86.00 ➝ $109.00Low
12/14/2021The Goldman Sachs GroupInitiated CoverageNeutral$83.00High
12/13/2021Truist FinancialBoost TargetBuy$90.00 ➝ $94.00Low
12/13/2021Wolfe ResearchBoost TargetOutperform$72.00 ➝ $80.00Low
12/13/2021StephensBoost TargetOverweight ➝ Overweight$82.00 ➝ $102.00Low
12/13/2021Bank of AmericaBoost TargetBuy$85.00 ➝ $93.00Low
12/13/2021OppenheimerBoost TargetOutperform ➝ Outperform$90.00 ➝ $95.00Low
12/13/2021Wells Fargo & CompanyBoost TargetOverweight$88.00 ➝ $90.00Medium
12/13/2021Credit Suisse GroupBoost TargetNeutral ➝ Neutral$75.00 ➝ $86.00Medium
12/13/2021BMO Capital MarketsBoost TargetOutperform ➝ Outperform$93.00 ➝ $100.00Medium
12/13/2021MizuhoBoost TargetNeutral ➝ Neutral$70.00 ➝ $78.00Medium
11/1/2021CitigroupDowngradeBuy ➝ Neutral$77.00Medium
10/27/2021Credit Suisse GroupBoost TargetNeutral$70.00 ➝ $75.00High
10/27/2021Morgan StanleyBoost TargetOverweight$79.00 ➝ $86.00High
9/14/2021Credit Suisse GroupLower TargetNeutral$73.50 ➝ $70.00High
9/14/2021Morgan StanleyLower TargetOverweight$88.00 ➝ $79.00High
9/9/2021CowenInitiated CoverageOutperform$87.00High
9/8/2021MizuhoLower TargetNeutral$75.00 ➝ $67.00Medium
8/31/2021Morgan StanleyLower TargetOverweight$94.00 ➝ $88.00Medium
8/17/2021Roth CapitalInitiated CoverageBuyHigh
8/3/2021Wells Fargo & CompanyLower TargetOverweight$93.00 ➝ $88.00Low
7/9/2021Seaport Res PtnReiterated RatingBuyLow
6/17/2021CitigroupBoost TargetBuy ➝ Buy$80.00 ➝ $86.00Medium
6/17/2021Wells Fargo & CompanyBoost TargetOverweight$87.00 ➝ $93.00High
6/17/2021OppenheimerReiterated RatingBuy$90.00High
6/17/2021BMO Capital MarketsBoost TargetPositive ➝ Outperform$88.00 ➝ $93.00High
6/17/2021MizuhoBoost TargetNeutral$65.00 ➝ $75.00High
6/8/2021Bank of AmericaBoost TargetBuy$75.00 ➝ $85.00Low
5/24/2021Wells Fargo & CompanyInitiated CoverageOverweight$87.00N/A
5/18/2021Wells Fargo & CompanyInitiated CoverageOverweight$87.00Low
5/11/2021BMO Capital MarketsBoost TargetOutperform$77.00 ➝ $88.00Medium
5/11/2021StephensUpgradeEqual Weight ➝ Overweight$71.00 ➝ $87.00Medium
4/28/2021BMO Capital MarketsLower Target$88.00 ➝ $77.00Medium
3/15/2021MizuhoInitiated CoverageNeutral$65.00N/A
3/9/2021MizuhoInitiated CoverageNeutral$65.00Low
1/21/2021The Goldman Sachs GroupInitiated CoverageNeutralLow
1/15/2021Jefferies Financial GroupDowngradeBuy ➝ Hold$75.00 ➝ $72.00Medium
12/21/2020Deutsche Bank AktiengesellschaftLower TargetBuy$83.00 ➝ $77.00Medium
12/14/2020SVB LeerinkLower TargetOutperform$80.00 ➝ $75.00High
11/11/2020Piper SandlerBoost TargetOverweight$83.00 ➝ $89.00Medium
10/28/2020Credit Suisse GroupLower TargetNeutral$72.50 ➝ $67.50Medium
10/28/2020Deutsche Bank AktiengesellschaftLower TargetBuy$87.00 ➝ $83.00High
10/28/2020SVB LeerinkBoost TargetOutperform$78.00 ➝ $80.00High
9/22/2020StephensDowngradeOverweight ➝ Equal WeightMedium
9/22/2020BarclaysBoost TargetOverweight$72.00 ➝ $84.00High
7/29/2020Jefferies Financial GroupLower TargetBuy$85.00 ➝ $83.00Low
7/29/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$80.00 ➝ $87.00Medium
7/1/2020SVB LeerinkInitiated CoverageOutperform$78.00High
6/12/2020OppenheimerInitiated CoverageBuy$90.00Low
4/29/2020Bank of AmericaReiterated RatingBuy$82.00Low
4/29/2020Credit Suisse GroupReiterated RatingHold$72.50Low
4/29/2020CitigroupBoost TargetBuy$70.00 ➝ $81.00High
4/29/2020OppenheimerBoost TargetOutperform$83.00 ➝ $90.00High
4/29/2020Deutsche Bank AktiengesellschaftLower TargetBuy$82.00 ➝ $80.00High
4/28/2020OppenheimerReiterated RatingBuy$83.00High
4/13/2020Morgan StanleyBoost TargetOverweight$85.00 ➝ $89.00Low
4/13/2020SunTrust BanksBoost TargetBuy$85.00 ➝ $90.00High
3/27/2020Morgan StanleyBoost TargetOverweight$82.00 ➝ $85.00Low
3/6/2020Deutsche Bank AktiengesellschaftLower TargetBuy$84.00 ➝ $82.00Medium
2/18/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$68.00 ➝ $84.00High
2/7/2020The Goldman Sachs GroupInitiated CoverageBuy$80.00Low
2/5/2020CitigroupBoost TargetBuy$65.00 ➝ $72.00High
2/5/2020JPMorgan Chase & Co.Initiated CoverageNeutral ➝ Overweight$88.00High
2/5/2020Credit Suisse GroupBoost TargetNeutral$65.00 ➝ $72.50High
2/4/2020OppenheimerInitiated CoverageBuy$83.00High
2/3/2020Evercore ISIInitiated CoverageOutperform$90.00Low
1/28/2020Sanford C. BernsteinBoost TargetTop Pick$84.00 ➝ $103.00High
1/24/2020SunTrust BanksReiterated RatingBuy$77.00 ➝ $85.00Low
1/24/2020Wells Fargo & CompanyBoost TargetOverweight$72.00 ➝ $85.00High
1/8/2020Credit Suisse GroupBoost TargetNeutral$57.00 ➝ $65.00High
1/6/2020Wolfe ResearchUpgradePeer Perform ➝ Outperform$72.00High
12/16/2019Piper Sandler CompaniesReiterated RatingBuy$80.00Medium
12/16/2019BMO Capital MarketsBoost TargetPositive ➝ Outperform$65.00 ➝ $70.00High
10/23/2019Deutsche Bank AktiengesellschaftLower TargetBuy$62.00 ➝ $60.00Low
10/23/2019Credit Suisse GroupLower TargetNeutral$63.00 ➝ $57.00High
9/26/2019Morgan StanleyLower TargetOverweight$64.00 ➝ $62.00High
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$62.00High
8/23/2019Morgan StanleyLower TargetOverweight$71.00 ➝ $64.00Medium
7/12/2019Morgan StanleyLower TargetOverweight$75.00 ➝ $71.00Medium
5/10/2019CitigroupUpgradeNeutral ➝ Buy$69.00Medium
4/24/2019SunTrust BanksLower TargetBuy$80.00Low
4/24/2019Morgan StanleyLower TargetOverweight ➝ Overweight$83.00 ➝ $75.00Low
4/21/2019Cantor FitzgeraldReiterated RatingBuy$83.00Low
3/31/2019CowenReiterated RatingBuy$77.00Low
3/29/2019Credit Suisse GroupLower TargetNeutral ➝ Neutral$76.00 ➝ $63.00Low
3/29/2019ArgusDowngradeHoldLow
2/28/2019CowenInitiated CoverageOutperform$77.00High
2/27/2019Cantor FitzgeraldReiterated RatingBuy$83.00Medium
(Data available from 2/24/2019 forward)

News Sentiment Rating

0.89 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 27 very positive mentions
  • 29 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
7/29/2023
  • 19 very positive mentions
  • 13 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
8/28/2023
  • 35 very positive mentions
  • 16 positive mentions
  • 5 negative mentions
  • 1 very negative mentions
9/27/2023
  • 38 very positive mentions
  • 25 positive mentions
  • 8 negative mentions
  • 2 very negative mentions
10/27/2023
  • 17 very positive mentions
  • 18 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
11/26/2023
  • 41 very positive mentions
  • 20 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
12/26/2023
  • 34 very positive mentions
  • 18 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
1/25/2024
  • 50 very positive mentions
  • 46 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
2/24/2024

Current Sentiment

  • 50 very positive mentions
  • 46 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Centene logo
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. It operates in two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. This segment also provides a variety of individual, small group, and large group commercial healthcare products to employers and members. This segment also offers various individual, small group, and large group commercial healthcare products to employers and members. The Specialty Services segment offers behavioral health and employee assistance plans; clinical healthcare, primary care, various specialty services, and a suite of social and other support services; data analytics solutions; administrative services to Military Health System eligible beneficiaries; traditional pharmacy clinical and administrative services as well as specialized pharmacy benefit services through its specialty pharmacy business; and vision and dental health services. This segment provides auxiliary healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations; and engages in the government contracts business under the TRICARE program and other healthcare related government contracts. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
Read More

Today's Range

Now: $80.22
Low: $79.60
High: $80.70

50 Day Range

MA: $76.20
Low: $72.21
High: $80.20

52 Week Range

Now: $80.22
Low: $60.83
High: $80.70

Volume

2,136,803 shs

Average Volume

2,662,241 shs

Market Capitalization

$42.91 billion

P/E Ratio

16.34

Dividend Yield

N/A

Beta

0.36

Frequently Asked Questions

What sell-side analysts currently cover shares of Centene?

The following equities research analysts have issued stock ratings on Centene in the last twelve months: Bank of America Co., Barclays PLC, Cantor Fitzgerald, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Morgan Stanley, Oppenheimer Holdings Inc., Stephens, StockNews.com, TheStreet, Truist Financial Co., UBS Group AG, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for CNC.

What is the current price target for Centene?

14 Wall Street analysts have set twelve-month price targets for Centene in the last year. Their average twelve-month price target is $83.57, suggesting a possible upside of 4.2%. Oppenheimer Holdings Inc. has the highest price target set, predicting CNC will reach $110.00 in the next twelve months. Bank of America Co. has the lowest price target set, forecasting a price of $72.00 for Centene in the next year.
View the latest price targets for CNC.

What is the current consensus analyst rating for Centene?

Centene currently has 6 hold ratings and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for CNC.

What other companies compete with Centene?

How do I contact Centene's investor relations team?

Centene's physical mailing address is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. The company's listed phone number is (314) 725-4477 and its investor relations email address is [email protected]. The official website for Centene is www.centene.com. Learn More about contacing Centene investor relations.